Publicacións (109) Publicacións de Luis Miguel Antón Aparicio

2021

  1. Signaling pathways in CRC

    Foundations of Colorectal Cancer (Elsevier), pp. 519-528

2020

  1. A new scenario in metastatic renal cell carcinoma: a SOG-GU consensus

    Clinical and Translational Oncology, Vol. 22, Núm. 9, pp. 1565-1579

2019

  1. “Oncofrail”: Oncología en la fragilidad. Desde la reflexión ética a la práctica clínica

    Eidon: revista de la fundación de ciencias de la salud, Núm. 51, pp. 4-15

2018

  1. Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies

    Expert Opinion on Drug Safety, Vol. 17, Núm. 6, pp. 573-579

2017

  1. Tyrosine kinase inhibitors reprogramming immunity in renal cell carcinoma: rethinking cancer immunotherapy

    Clinical and Translational Oncology, Vol. 19, Núm. 10, pp. 1175-1182

2016

  1. Medicina paliativa: libro del curso de "Especialista en cuidados paliativos" dir.

    Trama

  2. Role of taxanes in advanced prostate cancer

    Clinical and Translational Oncology, Vol. 18, Núm. 10, pp. 972-980

2015

  1. Circulating miR-200c and miR-141 and outcomes in patients with breast cancer

    BMC Cancer, Vol. 15, Núm. 1

  2. Clinical implications of epithelial cell plasticity in cancer progression

    Cancer Letters, Vol. 366, Núm. 1, pp. 1-10

  3. Cáncer colorrectal: un modelo darwiniano de inmuno-selección celular

    Abordaje multidisciplinar de cáncer colorrectal (Andavira), pp. 453-470

  4. Células madre y cáncer de colon

    Abordaje multidisciplinar de cáncer colorrectal (Andavira), pp. 425-438

  5. Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: A retrospective cross-sectional analysis

    BMC Cancer, Vol. 15, Núm. 1

  6. Radium-223 dichloride: A new paradigm in the treatment of prostate cancer

    Expert Review of Anticancer Therapy, Vol. 15, Núm. 3, pp. 339-348

  7. Side effects of targeted therapy

    Springer New York, pp. 377-416

  8. Treatment Of Sunitinib-Induced Hypertension In Solid Tumors By Nitric Oxid Donors

    Redox biology, Vol. 5, pp. 422

  9. Treatment of sunitinib-induced hypertension in solid tumor by nitric oxide donors

    Redox Biology, Vol. 6, pp. 421-425

  10. Vías de señalización en cáncer de colon

    Abordaje multidisciplinar de cáncer colorrectal (Andavira), pp. 439-452

2014

  1. Cabazitaxel for metastatic castration-resistant prostate cancer: Safety data from the Spanish expanded access program

    Expert Opinion on Drug Safety, Vol. 13, Núm. 9, pp. 1165-1173

  2. Cancer stem cells in genitourinary cancer

    Stem Cells in Cancer: Should We Believe or Not? (Springer Netherlands), pp. 149-165

  3. Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer

    Future Oncology, Vol. 10, Núm. 7, pp. 1187-1202